Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$15.93 - $22.26 $10,991 - $15,359
-690 Reduced 1.51%
44,884 $990,000
Q1 2024

May 14, 2024

SELL
$15.55 - $19.42 $175,777 - $219,523
-11,304 Reduced 19.87%
45,574 $833,000
Q4 2023

Feb 13, 2024

BUY
$17.18 - $22.38 $977,164 - $1.27 Million
56,878 New
56,878 $1.12 Million
Q3 2023

Nov 13, 2023

BUY
$15.0 - $20.71 $346,995 - $479,084
23,133 New
23,133 $455,000
Q4 2018

Feb 13, 2019

SELL
$21.6 - $37.49 $307,800 - $534,232
-14,250 Reduced 6.0%
223,367 $5.24 Million
Q3 2018

Nov 02, 2018

BUY
$25.67 - $42.36 $641,082 - $1.06 Million
24,974 Added 11.74%
237,617 $9.34 Million
Q2 2018

Aug 08, 2018

BUY
$17.91 - $26.86 $3.81 Million - $5.71 Million
212,643 New
212,643 $5.71 Million

Others Institutions Holding PETQ

About PetIQ, Inc.


  • Ticker PETQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,312,800
  • Market Cap $908M
  • Description
  • PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...
More about PETQ
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.